✦ LIBER ✦

Arrhythmia Induction by Antiarrhythmic Drugs

✍ Scribed by PEDRO BRUGADA; JOSEP BRUGADA; RAMON BRUGADA

Book ID: 109200382
Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 225 KB
Volume: 23
Category: Article
ISSN: 0147-8389
DOI: 10.1111/j.1540-8159.2000.tb06751.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aggravation of ventricular arrhythmia by

Aggravation of ventricular arrhythmia by antiarrhythmic drugs

📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Clinical predictors of arrhythmia worsen

Clinical predictors of arrhythmia worsening by antiarrhythmic drugs

✍ William Slater; Steven Lampert; Philip J. Podrid; Bernard Lown 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 679 KB

Oral Antiarrhythmic Drugs Used for Arrhy

Oral Antiarrhythmic Drugs Used for Arrhythmia Prevention

✍ Richard J. Lewis; Jonathan S. Steinberg 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 70 KB

Oral Antiarrhythmic Drugs Used for Arrhy

Oral Antiarrhythmic Drugs Used for Arrhythmia Prevention

✍ Bengt Herweg; Jonathan S. Steinberg 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 94 KB

Why are some antiarrhythmic drugs proarr

Why are some antiarrhythmic drugs proarrhythmic?: Cardiac arrhythmia study by bifurcation analysis

✍ Teresa Ree Chay 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 656 KB

Better antiarrhythmics? Development of a

Better antiarrhythmics? Development of antiarrhythmic drugs selective for ischaemia-dependent arrhythmias

✍ Allen I. Bain; Terrance D. Barrett; Gregory N. Beatch; David Fedida; Eric S. Hay 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

RSD1000 is one example of a series of compounds synthesized by Nortran Pharmaceuticals, Inc., to provide selective protection against arrhythmias due to myocardial ischaemia and so providing better therapeutic indices than existing drugs. RSD1019 is an analogue of RSD1000, whose therapeutic indices